A Shared Molecular and Genetic Basis for Food and Drug Addiction: Overcoming Hypodopaminergic Trait/State by Incorporating Dopamine Agonistic Therapy in Psychiatry

Psychiatr Clin North Am. 2015 Sep;38(3):419-62. doi: 10.1016/j.psc.2015.05.011.

Abstract

This article focuses on the shared molecular and neurogenetics of food and drug addiction tied to the understanding of reward deficiency syndrome. Reward deficiency syndrome describes a hypodopaminergic trait/state that provides a rationale for commonality in approaches for treating long-term reduced dopamine function across the reward brain regions. The identification of the role of DNA polymorphic associations with reward circuitry has resulted in new understanding of all addictive behaviors.

Keywords: Dopamine agonistic therapy; Drug addiction; Food addiction; Genetic basis; Hypodopaminergic state; Molecular basis; Psychiatry.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Review

MeSH terms

  • Animals
  • Behavior, Addictive / drug therapy*
  • Behavior, Addictive / genetics*
  • Brain / drug effects
  • Bulimia / drug therapy
  • Bulimia / genetics
  • Dopamine Agonists / pharmacology*
  • Dopamine Agonists / therapeutic use*
  • Eating / drug effects
  • Eating / genetics
  • Humans
  • Models, Neurological
  • Reward
  • Substance-Related Disorders / drug therapy*
  • Substance-Related Disorders / genetics*

Substances

  • Dopamine Agonists